- PMID: 37587466
- DOI: 10.1186/s12954-023-00842-6
Abstract
Background: The opioid crisis continues in full force, as physicians and caregivers are desperate for resources to help patients with opioid use and chronic pain disorders find safer and more accessible non-opioid tools.
Main body: The purpose of this article is to review the current state of the opioid epidemic; the shifting picture of cannabinoids; and the research, policy, and current events that make opioid risk reduction an urgent public health challenge. The provided table contains an evidence-based clinical framework for the utilization of cannabinoids to treat patients with chronic pain who are dependent on opioids, seeking alternatives to opioids, and tapering opioids.
Conclusion: Based on a comprehensive review of the literature and epidemiological evidence to date, cannabinoids stand to be one of the most interesting, safe, and accessible tools available to attenuate the devastation resulting from the misuse and abuse of opioid narcotics. Considering the urgency of the opioid epidemic and broadening of cannabinoid accessibility amidst absent prescribing guidelines, the authors recommend use of this clinical framework in the contexts of both clinical research continuity and patient care.
Keywords: Cannabinoids, Chronic pain, Opioids
© 2023. BioMed Central Ltd., part of Springer Nature.
References
-
- Organization WH. Opioid Overdose: WHO Newsroom 2021. https://www.who.int/news-room/fact-sheets/detail/opioid-overdose .
-
- Centers for Disease Control and Prevention. 2019 annual surveillance report of drug-related risks and outcomes—United States surveillance special report 2019 [June 6, 2022]. https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillancerep… .